Panacea Acquisition II priced its IPO of 15 million Class A ordinary shares at $10 each. Shares begin trading today on the Nasdaq under PANA.
The SPAC is sponsored by EcoR1 Panacea Holdings II, an affiliate of EcoR1 Capital.
Panacea II is searching for a target business operating in the biotechnology sector and based in North America or Europe. Read more.
